Ekso Bionics Holdings, Inc.
NASDAQ Capital MarketRecent
price
P/E
ratio
div
yld
- -
ROIC.AI
Capital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- Similar Companies
- Business
- Ekso Bionics Holdings, Inc. is a robotics company specializing in the design, manufacture, and sale of exoskeleton products developed to enhance human mobility and strength. Its core product portfolio includes industrial exoskeletons designed for occupational health and safety applications; medical-grade exoskeletons used in rehabilitation and physical therapy; and personal mobility devices for ambulatory assistance. The company’s exoskeletons are engineered for industries such as manufacturing, construction, logistics, and healthcare, targeting both commercial and medical markets primarily in North America, Europe, and select international regions. Founded in 2005 and headquartered in Richmond, California, Ekso Bionics focuses on advancing wearable robotics technologies that improve worker safety and patient rehabilitation outcomes. Recently, Ekso Bionics has strengthened its market position through key strategic initiatives including launching new product models that integrate advanced sensor technologies for improved user interface and ergonomic design. The company has also expanded partnerships with leading healthcare institutions to broaden clinical applications of its rehabilitation exoskeletons and has pursued business development efforts in industrial markets to grow adoption among large-scale manufacturers. These efforts are coupled with ongoing research and development projects to enhance exoskeleton adaptability and functionality, supporting a significant strategic shift towards comprehensive, customizable wearable robotic solutions. No name changes or corporate reorganizations have been publicly reported in the last two years, maintaining a stable brand identity focused on innovation and market expansion. Ekso Bionics continues to operate as a publicly traded company under the ticker EKSO. This description reflects Ekso Bionics’ position as a leader in the wearable robotics industry, offering specialized exoskeleton products and solutions designed to meet the evolving needs of industrial safety and medical rehabilitation markets. Its ongoing product innovations and strategic collaborations underscore the company’s commitment to expanding the utility and accessibility of robotic exoskeleton technology globally.
ChronoScale Appoints Cenly Chen as Chief Executive Officer to Lead Next Phase of AI Compute Growth
Insider Buying: Ekso Bionics (NASDAQ:EKSO) Major Shareholder Purchases $191,142.00 in Stock
Ekso Bionics Prices $5.852 million Private Placement
Why Applied Digital Stock Is Jumping Today
Halper Sadeh LLC Encourages EKSO, FOLD, CWAN, JHG Shareholders to Contact the Firm to Discuss Their Rights
$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of EKSO Bionics Holdings, Inc. (NASDAQ: EKSO)
Consumer Tech News (Dec 31-Jan 2): Wall Street Braces for Sluggish 2026 Start, AI Spending, and Chip Wars Define Market Pulse & More
Applied Digital and EKSO Bionics Plan Strategic Business Combination
Halper Sadeh LLC Encourages EKSO, FOLD, WBD, CFLT Shareholders to Contact the Firm to Discuss Their Rights
Applied Digital And The EKSO Transaction: Buy This Clear Story
EKSO Stock Alert: Halper Sadeh LLC is Investigating Whether the Merger of EKSO Bionics Holdings, Inc. Is Fair to Shareholders
Applied Digital to Spin Out Cloud Business, Proposes Business Combination with EKSO to Launch ChronoScale
Ekso Bionics Inks Agreement to Become the Exclusive U.S. Distributor of MediTouch's Groundbreaking BalanceTutor™ Rehabilitation System
Ekso Bionics (EKSO) Upgraded to Buy: Here's Why
Ekso Bionics Announces $3.7 Million Registered Direct Offering of Common Stock Priced At-the-Market under Nasdaq Rules
Ekso Bionics (EKSO) Reports Q3 Loss, Beats Revenue Estimates
Ekso Bionics Reports Third Quarter 2025 Financial Results
Ekso Bionics (EKSO) Upgraded to Buy: Here's What You Should Know
Ekso Bionics (EKSO) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now
Ekso Bionics Holdings, Inc. (EKSO) Q2 2025 Earnings Call Transcript